Suppression of proline-directed protein kinase F A potentiates apoptotic induction and greatly enhances chemosensitivity in human acute lymphoblastic leukemia cells

Cancer

Volumn 92, Issue 7, 2001, Pages 1753-1758

  Hsu, Chih Ping ^a   Yang, Chuan Ching ^a   Hsueh, Sheng Fen ^a   Peng, Chien Chung ^a   Fu, Hsiao Hui ^a   Yang, Shiaw Der ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Chemosensitivity; Human acute lymphoblastic leukemia cells; Proline directed protein kinase

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; METHOTREXATE; PACLITAXEL; PROLINE; PROTEIN KINASE; PROTEIN KINASE F A; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; PROLINE-DIRECTED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035477358     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011001)92:7<1753::AID-CNCR1690>3.0.CO;2-V     Document Type: Article

References (17)

1. Apoptosis in cancer therapy: Crossing the threshold
2. Relapsed lymphoblastic leukemia in children: A continuing challenge
3. Dose-intensive therapy for acute lymphoblastic leukemia
4. A/GSK-3α correlates with human thyroid tumor cell dedifferentiation
5. A/GSK-3α (a proline-directed kinase and a regulator of protooncogenes) with human cervical carcinoma dedifferentiation/progression
6. A/GSK-3α (a proline-directed protein kinase) correlates with human hepatoma dedifferentiation/progression
7. A/GSK-3α in well- and poorly-differentiated human prostate carcinoma cells
8. A expression inhibits the growth of human chronic myeloid leukemia cells
9. A systemically inhibits the growth of human acute leukemia cells
10. A enhances chemosensitivity in human prostate cancer cells
11. A expression potentiates erythroid differentiation of human myeloid leukemia cell
12. Re-examination and further development of precise and rapid dye method for measuring cell growth/cell killing
13. Morphological assessment of apoptosis
14. Multidrug resistance-a multiplex phenomenon
15. Apoptosis and chemotherapy resistance
16. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
17. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB